Live event participants can earn up to 1 CPE credit in the Specialized Knowledge field of study.
Program description: ESG has become increasingly more important for all stakeholders in the life science industry. As such, organizations are taking inventory of their current state ESG programs and are developing new strategies and roadmaps to create safer products to enhance the patient experience and journey. Organizations are focusing on quality beyond compliance, enhancing reporting to promote improved transparency across the broad spectrum of stakeholders, and are strategizing on ways to engage underserved communities through clinical trial programs; all of which fold into the three pillars of ESG. Comprehension of the maturity of an organization’s ESG program is imperative to prescribing a robust future state roadmap and strategy to meet the needs of stakeholders.
Program level: Overview
Prerequisites: None
Advanced Preparation: None
Topics to be discussed include:
- Understanding the current state of ESG in MedTech and Pharma, including:
- The three pillars of ESG
- Baseline reporting methodologies
- Challenges and trends
- Understanding the future state of ESG, including ethics and compliance considerations and ESG program maturity
Instructional Delivery Method: Group Internet Based
Who Should Attend: Those in the life sciences, MedTech, and pharma industries interested in learning more about the current state of ESG in in the industry.
Official NASBA sponsor statement, if an approved NASBA sponsor (explaining final authority of acceptance of CPE credits):
CohnReznick LLP is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State board of accountancy have final authority on the acceptance of individual courses for CPE credits. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: www.nasbaregistry.org
ON-DEMAND
